Mirtazapine identified as a preventive agent against cisplatin-induced nephrotoxicity: Integrating in silico, in vitro, and in vivo analyses
Abstract
Cisplatin (CDDP), a platinum-based chemotherapeutic agent, is highly effective in the treatment of various solid tumors. However, CDDP-induced nephrotoxicity (CIN) remains a critical dose-limiting toxicity that compromises CDDP's therapeutic efficacy in clinical practice. Since renal accumulation of CDDP, which is mediated by organic cation transporter 2 (OCT2/SLC22A2), contributes to the onset of CIN, OCT2 inhibitors may serve as prophylactic agents for CIN. In the present study, we aimed to identify potential preventive agents against CIN using a novel drug repositioning strategy that integrates quantitative structure-activity relationship-based screening for hOCT2 inhibitors with a Food and Drug Administration Adverse Event Reporting System analysis for CIN, and to evaluate their renoprotective effects through in vitro and in vivo experiments. Based on our in silico integrated analysis, seven compounds were selected as promising candidates for the prevention of CIN. An in vitro uptake study in hOCT2-expressing human embryonic kidney 293 cells comparing the seven compounds demonstrated that mirtazapine exhibited the highest inhibitory activity against hOCT2. In a CIN mouse model, concomitant administration of mirtazapine markedly attenuated the CDDP-induced increases in blood urea nitrogen and serum creatinine levels, mRNA expression of tubular injury markers, and histological renal damage in a dose-dependent manner. Furthermore, renal accumulation of CDDP was…
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.